Search Results 1641-1650 of 18020 for Lupus

  1. Chordoma - Care at Mayo Clinic

    Find out about this rare type of bone cancer. Learn about innovative chordoma treatments, including minimally invasive surgery and proton therapy.

  2. Small lymphocytic lymphoma - Doctors and departments - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.

  3. Science Saturday: Study finds senescent immune cells promote lung tumor growth - Mayo Clinic News Network

    Researchers have discovered a type of white blood cell in the lungs, called senescent macrophages, that promote tumor growth.

  4. Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients - Mayo Clinic

    The purpose of this study is to compare the efficacy and safety of eflornithine in combination with lomustine, compared to lomustine taken alone, in treating ...

  5. A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens - Mayo Clinic

    About this study. The purpose of this study is to evaluate the dose, safety, immunogenicity and early clinical activity of GRT-C903 and GRT-R904, ...

  6. Publications - Gustavo L. Knop, M.D. - Mayo Clinic

    Knop , G.L.. Primary Cardiac Lymphona Revista Agrgentina de Cardiologia. 2016; 84:249-250. Knop , G. Heart transplantation using donors after circulatory death: ...

  7. A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT) - Mayo Clinic

    -Progression free survival (as determined by the IWCLL criteria) among all patients. -The overall toxicity profile of daratumumab/ibrutinib treatment in this ...

  8. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  9. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    The purpose of this study is to compare the effectiveness and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in ...

  10. Mayo Clinic Researchers Discover New Form of Cancer

    Potentially disfiguring facial tumor caused by chromosomal chimera. ROCHESTER, Minn. — This is the story of two perfectly harmless genes.